文献速递银屑病与炎症性皮肤病

银屑病患者对窄谱中波紫外线(NB-UVB)的光适应研究

Photoadaptation to ultraviolet B TL01 in psoriatic patients.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2020-04-27

该研究纳入57例中度斑块状银屑病成人患者,接受每周3次共24次NB-UVB光疗,起始剂量为70%最小红斑量(MED),每两次治疗按百分比递增。结果显示光适应因子不受基线MED和皮肤类型影响;累积剂量与初始MED弱相关(Spearman's rho=0.32,P=0.0154),清除率与平均治疗次数相关(Spearman's rho=0.48,P<0.001)。结论认为光适应是影响NB-UVB疗效的生理反应,无法通过基线MED和皮肤类型预测。

要点

  • 光适应因子不受基线MED和皮肤类型影响,无法据此预测疗效。
  • 累积剂量与初始MED呈弱相关(rho=0.32,P=0.0154)。
  • 清除率与平均治疗次数相关(rho=0.48,P<0.001)。

核心结论

  • 光适应是影响NB-UVB疗效的生理反应,不能通过基线MED和皮肤类型预测。

研究设计与样本

  • 纳入57例中度斑块状银屑病成人患者,接受每周3次共24次NB-UVB光疗。
  • 起始剂量为70%最小红斑量(MED),每两次治疗按百分比递增剂量。
  • 基线及疗程结束时测量MED、红斑指数和黑素指数(MI),并计算每例患者的光适应因子(AF)。

主要发现

  • 光适应因子不受基线MED和皮肤类型影响。
  • 较高累积剂量与初始MED呈弱相关(Spearman's rho=0.32,P=0.0154)。
  • 较高累积剂量与平均初始MI呈临界弱相关(Spearman's rho=0.25,P=0.0624)。
  • 清除率与平均治疗次数相关(Spearman's rho=0.48,P<0.001)。

临床怎么用

  • 可考虑采用更积极的起始方案并加快剂量递增,以减少光适应、提高NB-UVB应答。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the biologic era, narrow-band ultraviolet B (NB-UVB) phototherapy still remains a valuable, effective, inexpensive, safe anti-psoriatic treatment. Patients can lose response to NB-UVB over time due to photoadaptation. This phenomenon is the tendency of the skin to respond to ultraviolet (UV) exposure by undergoing changes that may result in a decreased future response to an equivalent dose of radiation, thus leading to the need for an increased exposure during phototherapy course. AIM: To characterize and quantify the determinants of photoadaptation in NB-UVB treated psoriatic patients. METHODS: We enrolled 57 adult patients with moderate plaque psoriasis. Patients underwent 24 sessions of NB-UVB phototherapy delivered thrice a week. Dosing was started with 70% of the minimal erythema dose (MED) with percentage-based dose increments every two treatments. MED as well as change in the erythema and melanin index (MI) were measured at baseline and at the end of phototherapy course. Moreover, an adaptation factor (AF) was calculated for each patient. RESULTS: Adaptation factor was not influenced by both baseline MED and skin type. We found a weak correlation between higher cumulative dosages and the initial MED (Spearman's rho = 0.32, P = 0.0154) as well as with the mean initial MI (Spearman's rho = 0.25, P = 0.0624, statistically borderline). Clearance and mean number of treatments were correlated (Spearman's rho = 0.48, P < 0.001). CONCLUSION: Photoadaptation is a physiological skin response that negatively influences NB-UVB responsiveness and is not predictable by the baseline MED and skin type. Thus, starting with more aggressive protocols and increasing rapidly dosage progression to prevent AF may increase NB-UVB response.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Pacifico A, Damiani G, Iacovelli P, et al. Photoadaptation to ultraviolet B TL01 in psoriatic patients. J Eur Acad Dermatol Venereol. 2020. PMID: 31967696. doi:10.1111/jdv.16209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。